TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

ABN: 71095610870Sydney, NSW
Enterprise ($50M+)
+82.9% YoY
$577.7M
Total Value
4
Total Contracts
Drugs and Pharmaceutical
Primary Category

Recent Contracts

Active
Drugs and Pharmaceutical
4 Sept 2025
CN3743080—National Supply arrangement for imported immunoglobulin products$434.1M

31 Dec 2020 - 30 Dec 2027

National Blood Authority
Active
Drugs and Pharmaceutical
18 July 2025
CN4171512—Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate$22.3M

30 June 2025 - 29 June 2028

National Blood Authority
Expired
Drugs and Pharmaceutical
5 July 2024
CN3737775—Supply of Advate and Adynovate Imported Plasma and Recombinant Products$109.5M

31 Dec 2019 - 29 June 2025

National Blood Authority

1 more contracts available

Retender Opportunities

10 expiring contracts in this supplier's categories that may be retendered soon.

Unlock 10 retender opportunities

See contract values, current suppliers, and exact expiry dates.

Peer Benchmarking

See how TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD. ranks against similar companies in their category and size band.

Financial Year Breakdown

FY25
$22.3M(1 contracts)
FY23
$11.8M(1 contracts)

2 more years available

Unlock full history →

Company Details

Name
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
Entity Type
Australian Private Company
ABN
71 095 610 870
ACN
095 610 870
Status
Registered
Registered
16 Jan 2001
Previously known as
ALTANA PHARMA PTY LTD, BYK GULDEN AUSTRALIA PTY. LTD., NYCOMED PTY LTD
Town/City
Sydney
Postcode
2000
State/Territory
NSW
Country
Australia

Similar Suppliers

GLAXOSMITHKLINE AUSTRALIA PTY LTD$1.6BPFIZER AUSTRALIA PTY LTD$760.9MSEQIRUS (AUSTRALIA) PTY LTD$1.8BROCHE PRODUCTS PTY LTD$670.9MSANOFI-AVENTIS AUSTRALIA PTY LTD$528.8M